Prospective Study of Rapamycin for the Treatment of SLE (Rapamune)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Pfizer
Information provided by (Responsible Party):
Andras Perl, MD, Ph.D, State University of New York - Upstate Medical University
ClinicalTrials.gov Identifier:
NCT00779194
First received: October 23, 2008
Last updated: February 5, 2015
Last verified: February 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)